We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Nutra Pharma Provides Updates on Laboratory Upgrades and Certifications Nutra Pharma is providing updates on their work in improving capabilities and...
Nutra Pharma Announces New Intellectual Property Update and Engages Additional Intellectual Property Attorneys Plantation, FL -- February 12, 2021 --InvestorsHub...
CORAL SPRINGS, Fla., July 24, 2014 (GLOBE NEWSWIRE) -- Nutra Pharma Corp. (OTCPink:NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple...
Nutra Pharma Announces Nyloxin Television Commercial Rollout Nutra Pharma Is Announcing That MyNyloxin.com Has Begun the Rollout of Television Commercials for Their Marketing Campaign of the...
Nutra Pharma Announces Completion of Commercials by MyNyloxin.com Nutra Pharma Is Announcing That MyNyloxin.com Has Completed a Series of Commercials for Their Marketing Campaign of the Company's...
Nutra Pharma Announces Contracts for Nyloxin Television Commercials Nutra Pharma Is Announcing That MyNyloxin.com Has Contracted for the Rollout of Television Commercials for Their Marketing...
Nutra Pharma Announces Completion of Commercials by MyNyloxin.com Nutra Pharma Is Announcing That MyNyloxin.com Has Completed a Series of Commercials for Their Marketing Campaign of the Company's...
Nutra Pharma to Seek GSA Certification, Will Market Military Strength Nyloxin to Governmental Agencies and the DoD Nutra Pharma Is Announcing That They Are in the Process of Completing Their GSA...
Nutra Pharma Announces New Telemarketing and Social Media Campaign Through MyNyloxin.com Nutra Pharma Is Announcing That MyNyloxin.com Is Beginning a Social Media and Telemarketing Campaign for...
Nutra Pharma Announces the First Shipments and Product Delivery to MyNyloxin.com Independent Entrepreneurs Nutra Pharma Is Announcing the Initial Shipments and Delivery of the Company's...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0.0001 | 0 | 0 | 0 | CS |
4 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 18250 | 8.46E-6 | CS |
12 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 39452 | 5.016E-5 | CS |
26 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 250261 | 9.658E-5 | CS |
52 | 9.9E-5 | 9900 | 1.0E-6 | 0.0017 | 1.0E-6 | 398935 | 0.00014239 | CS |
156 | -0.0017 | -94.4444444444 | 0.0018 | 0.0038 | 1.0E-6 | 619215 | 0.0009845 | CS |
260 | -0.0003 | -75 | 0.0004 | 0.0158 | 1.0E-6 | 10835872 | 0.00314367 | CS |
Symbol | Price | Vol. |
---|---|---|
AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0.00275 (0.00%) | 51.06M |
GTEHGenTech Holdings Inc (CE) | US$ 0.000001 (0.00%) | 48.25M |
HMBLHUMBL Inc (PK) | US$ 0.0002 (-33.33%) | 42.65M |
CBGLCannabis Global Inc (PK) | US$ 0.00015 (50.00%) | 41.81M |
GTVHGolden Triangle Ventures Inc (PK) | US$ 0.0008 (33.33%) | 41.61M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions